arrow
A

Ann Driessen

antwerp university
H指数:46
被引数:7,149

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ECCO Topical Review on IBD-like patterns of drug colitis with practical guidance and a focus on immune checkpoint inhibitors

ECCO 专题综述:药物性结肠炎的炎症性肠病样模式,实用指南及免疫检查点抑制剂的聚焦

2026-01-010
PRE
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2

Yanai, H.; Feakins, R.; Allocca, M.; Burisch, J.; Ellul, P.; Iacucci, M.; Maaser, C.; Zilli, A.; Zidar, N.; Wilkens, R.; 等. ECCO-ESGAR-ESP-IBUS 关于炎症性肠病患者诊断与监测指南:第2部分. J. Crohn’s Colitis 2025, 19, jjaf106. [Google Scholar] [CrossRef]

2025-07-310
OAAI
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1

Kucharzik, T.; Taylor, S.; Allocca, M.; Burisch, J.; Ellul, P.; Iacucci, M.; Maaser, C.; Baldin, P.; Bhatnagar, G.; Ben-Horin, S.; 等. ECCO-ESGAR-ESP-IBUS 关于炎症性肠病患者诊断与监测指南:第一部分. J. Crohn’s Colitis 2025, 19, jjaf107. [Google Scholar] [CrossRef] [PubMed]

2025-07-0120
PRE
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

铁死亡是代谢功能障碍相关的脂肪性肝病的靶向有害因素

2024-07-262
OAAI
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

基于与人类代谢功能障碍相关的脂肪变性肝病 (MASLD) 的接近程度,对小鼠饮食模型进行无偏排名

2024-06-1233
OA
Organ-specific genome diversity of replication-competent SARS-CoV-2 (vol 12, 6612, 2021)
2022-10-212
OAAI
Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy
2022-01-2510
OAAI
Organ-specific genome diversity of replication-competent SARS-CoV-2

具有复制能力的SARS-CoV-2的器官特异性基因组多样性

2021-11-1649
OAAI
ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology Collaboration Between S-ECCO, EduCom, H-ECCO

ECCO专题审查优化手术,内窥镜检查和组织病理学报告s-ecco,EduCom,h-ecco之间的合作

2021-01-1130
OAAI
Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution (vol 1, pg 604, 2019)
2019-06-244
OAAI